GLRE
Greenlight Capital Re, Ltd.
Insurance - Reinsurance
Market Cap$606M
5Y Perf.+146.4%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
GLRE vs MS
Revenue, margins, valuation, and 5-year total return — side by side.
MS
Morgan Stanley
Financial - Capital Markets
Market Cap$307.53B
5Y Perf.+337.3%
GLRE vs MS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | GLRE | MS |
|---|---|---|
| Industry | Insurance - Reinsurance | Financial - Capital Markets |
| Market Cap | $606M | $307.53B |
| Revenue (TTM) | $706M | $103.14B |
| Net Income (TTM) | $81M | $16.18B |
| Gross Margin | 38.9% | 55.6% |
| Operating Margin | 6.7% | 17.1% |
| Forward P/E | 8.9x | 16.3x |
| Total Debt | $5M | $360.49B |
| Cash & Equiv. | $112M | $75.74B |
GLRE vs MS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
GLRE
MS
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Greenlight Capital … (GLRE) | 100 | 246.4 | +146.4% |
| Morgan Stanley (MS) | 100 | 437.3 | +337.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GLRE vs MS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MS leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Greenlight Capital Re, Ltd. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
GLRE
Greenlight Capital Re, Ltd.
The Insurance Pick
GLRE is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.40
- Lower volatility, beta 0.40, Low D/E 0.7%, current ratio 0.99x
- PEG 0.11 vs MS's 1.83
Best for: income & stability and sleep-well-at-night
MS
Morgan Stanley
The Banking Pick
MS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 16.8%, EPS growth 53.5%
- 7.4% 10Y total return vs GLRE's -15.3%
- 16.8% NII/revenue growth vs GLRE's 7.5%
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | MS | 16.8% NII/revenue growth vs GLRE's 7.5% |
| Value | GLRE | Lower P/E (8.9x vs 16.3x), PEG 0.11 vs 1.83 |
| Quality / Margins | MS | 13.0% margin vs GLRE's 11.5% |
| Stability / Safety | GLRE | Beta 0.40 vs MS's 1.37, lower leverage |
| Dividends | MS | 2.0% yield; 11-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | MS | +66.7% vs GLRE's +32.1% |
| Efficiency (ROA) | GLRE | 3.7% ROA vs MS's 1.2%, ROIC 9.5% vs 2.9% |
GLRE vs MS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2024
GLRE vs MS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLMSLAGGINGGLRE
GLREGreenlight Capital Re…
2leads
MSMorgan Stanley
3leads
6 Total Categories
CATEGORYLEADERvs GLREMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
MS4/5
Valuation MetricsMultiples, price ratios, and targets
GLRE6/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
GLRE8/9
Total Returns1Y, 3Y, 5Y total returns with dividends
MS5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
MS1/1
Income & Cash Flow (Last 12 Months)
MS leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
MS is the larger business by revenue, generating $103.1B annually — 146.0x GLRE's $706M. Profitability is closely matched — net margins range from 13.0% (MS) to 11.5% (GLRE).
| Metric | GLREGreenlight Capita… | MSMorgan Stanley |
|---|---|---|
| RevenueTrailing 12 months | $706M | $103.1B |
| EBITDAEarnings before interest/tax | $51M | $26.3B |
| Net IncomeAfter-tax profit | $81M | $16.2B |
| Free Cash FlowCash after capex | $237M | -$6.7B |
| Gross MarginGross profit ÷ Revenue | +38.9% | +55.6% |
| Operating MarginEBIT ÷ Revenue | +6.7% | +17.1% |
| Net MarginNet income ÷ Revenue | +11.5% | +13.0% |
| FCF MarginFCF ÷ Revenue | +33.6% | -2.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.6% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +22.1% | +48.9% |
MS leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
GLRE leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 8.2x trailing earnings, GLRE trades at a 66% valuation discount to MS's 24.3x P/E. Adjusting for growth (PEG ratio), GLRE offers better value at 0.10x vs MS's 2.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | GLREGreenlight Capita… | MSMorgan Stanley |
|---|---|---|
| Market CapShares × price | $606M | $307.5B |
| Enterprise ValueMkt cap + debt − cash | $499M | $592.3B |
| Trailing P/EPrice ÷ TTM EPS | 8.22x | 24.31x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.90x | 16.28x |
| PEG RatioP/E ÷ EPS growth rate | 0.10x | 2.73x |
| EV / EBITDAEnterprise value multiple | 6.01x | 26.03x |
| Price / SalesMarket cap ÷ Revenue | 0.87x | 2.98x |
| Price / BookPrice ÷ Book value/share | 0.87x | 2.95x |
| Price / FCFMarket cap ÷ FCF | 2.88x | — |
GLRE leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
GLRE leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
MS delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $12 for GLRE. GLRE carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MS's 3.42x. On the Piotroski fundamental quality scale (0–9), GLRE scores 7/9 vs MS's 5/9, reflecting strong financial health.
| Metric | GLREGreenlight Capita… | MSMorgan Stanley |
|---|---|---|
| ROE (TTM)Return on equity | +11.7% | +14.6% |
| ROA (TTM)Return on assets | +3.7% | +1.2% |
| ROICReturn on invested capital | +9.5% | +2.9% |
| ROCEReturn on capital employed | +6.0% | +3.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.01x | 3.42x |
| Net DebtTotal debt minus cash | -$107M | $284.7B |
| Cash & Equiv.Liquid assets | $112M | $75.7B |
| Total DebtShort + long-term debt | $5M | $360.5B |
| Interest CoverageEBIT ÷ Interest expense | 15.78x | 0.44x |
GLRE leads this category, winning 8 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
MS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MS five years ago would be worth $24,217 today (with dividends reinvested), compared to $19,800 for GLRE. Over the past 12 months, MS leads with a +66.7% total return vs GLRE's +32.1%. The 3-year compound annual growth rate (CAGR) favors MS at 34.3% vs GLRE's 20.6% — a key indicator of consistent wealth creation.
| Metric | GLREGreenlight Capita… | MSMorgan Stanley |
|---|---|---|
| YTD ReturnYear-to-date | +26.0% | +7.4% |
| 1-Year ReturnPast 12 months | +32.1% | +66.7% |
| 3-Year ReturnCumulative with dividends | +75.2% | +142.1% |
| 5-Year ReturnCumulative with dividends | +98.0% | +142.2% |
| 10-Year ReturnCumulative with dividends | -15.3% | +739.4% |
| CAGR (3Y)Annualised 3-year return | +20.6% | +34.3% |
MS leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — GLRE and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
GLRE is the less volatile stock with a 0.40 beta — it tends to amplify market swings less than MS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 99.2% from its 52-week high vs GLRE's 92.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | GLREGreenlight Capita… | MSMorgan Stanley |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.40x | 1.37x |
| 52-Week HighHighest price in past year | $19.39 | $194.83 |
| 52-Week LowLowest price in past year | $11.57 | $117.21 |
| % of 52W HighCurrent price vs 52-week peak | +92.0% | +99.2% |
| RSI (14)Momentum oscillator 0–100 | 50.5 | 61.2 |
| Avg Volume (50D)Average daily shares traded | 202K | 5.4M |
Evenly matched — GLRE and MS each lead in 1 of 2 comparable metrics.
Analyst Outlook
MS leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates GLRE as "Buy" and MS as "Buy". MS is the only dividend payer here at 1.97% yield — a key consideration for income-focused portfolios.
| Metric | GLREGreenlight Capita… | MSMorgan Stanley |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $205.75 |
| # AnalystsCovering analysts | 3 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +2.0% |
| Dividend StreakConsecutive years of raises | 1 | 11 |
| Dividend / ShareAnnual DPS | — | $3.81 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | +1.4% |
MS leads this category, winning 1 of 1 comparable metric.
Key Takeaway
MS leads in 3 of 6 categories (Income & Cash Flow, Total Returns). GLRE leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
Best OverallMorgan Stanley (MS)Leads 3 of 6 categories
Loading custom metrics...
GLRE vs MS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is GLRE or MS a better buy right now?
For growth investors, Morgan Stanley (MS) is the stronger pick with 16.
8% revenue growth year-over-year, versus 7. 5% for Greenlight Capital Re, Ltd. (GLRE). Greenlight Capital Re, Ltd. (GLRE) offers the better valuation at 8. 2x trailing P/E (8. 9x forward), making it the more compelling value choice. Analysts rate Greenlight Capital Re, Ltd. (GLRE) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GLRE or MS?
On trailing P/E, Greenlight Capital Re, Ltd.
(GLRE) is the cheapest at 8. 2x versus Morgan Stanley at 24. 3x. On forward P/E, Greenlight Capital Re, Ltd. is actually cheaper at 8. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Greenlight Capital Re, Ltd. wins at 0. 11x versus Morgan Stanley's 1. 83x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — GLRE or MS?
Over the past 5 years, Morgan Stanley (MS) delivered a total return of +142.
2%, compared to +98. 0% for Greenlight Capital Re, Ltd. (GLRE). Over 10 years, the gap is even starker: MS returned +739. 4% versus GLRE's -15. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GLRE or MS?
By beta (market sensitivity over 5 years), Greenlight Capital Re, Ltd.
(GLRE) is the lower-risk stock at 0. 40β versus Morgan Stanley's 1. 37β — meaning MS is approximately 244% more volatile than GLRE relative to the S&P 500. On balance sheet safety, Greenlight Capital Re, Ltd. (GLRE) carries a lower debt/equity ratio of 1% versus 3% for Morgan Stanley — giving it more financial flexibility in a downturn.
05Which is growing faster — GLRE or MS?
By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 16.
8% versus 7. 5% for Greenlight Capital Re, Ltd. (GLRE). On earnings-per-share growth, the picture is similar: Greenlight Capital Re, Ltd. grew EPS 75. 0% year-over-year, compared to 53. 5% for Morgan Stanley. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GLRE or MS?
Morgan Stanley (MS) is the more profitable company, earning 13.
0% net margin versus 10. 7% for Greenlight Capital Re, Ltd. — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MS leads at 17. 1% versus 11. 2% for GLRE. At the gross margin level — before operating expenses — MS leads at 55. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GLRE or MS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Greenlight Capital Re, Ltd. (GLRE) is the more undervalued stock at a PEG of 0. 11x versus Morgan Stanley's 1. 83x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Greenlight Capital Re, Ltd. (GLRE) trades at 8. 9x forward P/E versus 16. 3x for Morgan Stanley — 7. 4x cheaper on a one-year earnings basis.
08Which pays a better dividend — GLRE or MS?
In this comparison, MS (2.
0% yield) pays a dividend. GLRE does not pay a meaningful dividend and should not be held primarily for income.
09Is GLRE or MS better for a retirement portfolio?
For long-horizon retirement investors, Morgan Stanley (MS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2.
0% yield, +739. 4% 10Y return). Both have compounded well over 10 years (MS: +739. 4%, GLRE: -15. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GLRE and MS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GLRE is a small-cap deep-value stock; MS is a large-cap high-growth stock. MS pays a dividend while GLRE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(GLRE: 5.6% · MS: 16.8%)Net Margin>
%
(GLRE: 11.5% · MS: 13.0%)P/E Ratio<
x
(GLRE: 8.2x · MS: 24.3x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.